Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 151 - 200 out of 30,475

Document Document Title
WO/2016/079759A1
The present invention relates to a novel simple, efficient and single-step process for esterification of aldehydes using a heterogeneous catalyst with high yields. More particularly, the present invention relates to a novel simple, effic...  
WO/2016/079036A1
The present invention relates to a process for the one-pot hydrogenation and dehydration or isomerization of an organic compound, and to a catalyst composition for this process comprising transition metal particles having particle size b...  
WO/2016/078673A1
The present invention concerns a process for converting biomass into useful organic building blocks for the chemical industry. The process involves the reduction of a polyol wherein at least two of the hydroxyl groups are located on adja...  
WO/2016/076712A1
An ester composition comprising at least 90 %wt of the dialkyi ester of 2,5-furandicarboxylic acid as starting dialkyi ester concentration and up to 5%wt of the monoalkyi ester of 2,5-furandicarboxylic acid as starting monoalkyi ester co...  
WO/2016/076384A1
The present invention provides an organic EL element which sequentially comprises at least a positive electrode, a hole injection layer, a first hole transport layer, a second hole transport layer, a light emitting layer, an electron tra...  
WO/2016/076710A1
Dialkyl esters of 2,5-furandicarboxylic acid are prepared from a 2,5-furandicarboxylic acid-containing starting materialin a process, which comprises: -contacting a vaporous stream of an alkanol countercurrently with the at least partial...  
WO/2016/076711A1
Dialkyil esters of 2,5-furandicarboxylic acid are prepared in a process comprising: - contacting an acid starting composition comprising 2,5-furandicarboxylic acid with an excess of alkanol to form an esterification product comprising th...  
WO/2016/072366A1
Provided are: a novel production method for inexpensively producing, in high yield, a photopolymerizable compound used in liquid crystal display elements or the like; and a novel intermediate compound. In a method for producing a compoun...  
WO/2016/072365A1
Provided is a novel method for inexpensively producing, in high yield, a polymerizable compound useful for liquid crystal display elements. In this method for producing a compound represented by formula (3) (wherein n represents an integ...  
WO/2016/073529A1
Provided are compositions, comprising a neolignan, ectoin, and a molecule of Formula I: wherein R1, R2 and R3 are independently H, methyl, ethyl, propyl, or isopropyl; wherein X is S or O. In some cases, the molecule of Formula I is ergo...  
WO/2016/072854A3
The present invention concerns novel pantothenamide analogues of formula (I), having antimicrobial activity. In particular, the pantothenamide analogues of the present invention are not sensitive to pantetheinase activity. The pantothena...  
WO/2016/069321A3
There is disclosed a compound having Formula (I), Formula (II), Formula (III), Formula (VIII), Formula (IX), or Formula (X) The variables are described in detail in the application.  
WO/2016/068712A1
The invention relates to a method for preparing furanic compound crystals from sugars comprising the steps of - converting sugar or sugar alcohol into a furanic compound in a reaction mixture comprising an organic solvent, thereby obtain...  
WO/2016/066057A1
Disclosed is a 3-arylbenzofuranone compound characterized in that R1-R6 in the structural formula of 3-arylbenzofuranone compound are H or C1-C20 alkyl independently and R7 is C7-C20 alkyl or C7-C20 mixed alkyl. A composition formed from...  
WO/2016/069229A1
This invention relates to a dimethylterephthalate production process comprising reacting substituted furan with ethylene under cycloaddition reaction conditions and in the presence of a cycloaddition catalyst to produce a bicyclic ether,...  
WO/2016/069321A2
There is disclosed a compound having Formula (I), Formula (II), Formula (III), Formula (VIII), Formula (IX), or Formula (X) The variables are described in detail in the application.  
WO/2016/062587A1
The present invention relates to a compound of formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and G are as defined herein; and wherein the compound of formula (I) is optionally present as an agrochemically acceptable sa...  
WO/2016/062559A1
The invention relates to tetrahydrofuran derivatives of the formula (I) in which the R1 radical is defined as (CH2=CH-CO-O-(CHR3-CH2-O)m-CH2)- and the R2 radical is defined as (CH2=CH-CO-O-(CHR4-CH2-O)n-CH2)-, where the R3 and R4 radical...  
WO/2016/063990A1
The present invention relates to a compound represented by general formula (1). (The definition of each group in the formula is as described in the specification.) The compound is useful as a prophylactic and/or therapeutic agent for KCN...  
WO/2016/064711A1
This invention concerns a dosage form comprising a therapeutically effective amount of A19-144 or A2-73 and a therapeutically effective amount of at least one AED. This invention further encompasses a method of treating a subject in need...  
WO/2016/061862A1
A technique for preparing an amorphous posaconazole. Posaconazole is dissolved in a mixed solvent of an alcohol and an ester, is added to an alkane, a cycloalkane, or an arene, and undergoes precipitation so as to separate out jelly-like...  
WO/2016/063896A1
Provided is an ascorbic acid derivative that can be used to obtain a glycoside of which ascorbic acid is the aglycone. The abovementioned derivative is the compound represented by formula (A) (i.e., 2,3,6-tri-O-acyl-ascorbic acid). (In t...  
WO/2016/064445A1
Provided are compounds that target the lanthionine synthetase C-like protein 2 pathway. The compounds can be used to treat a number of conditions, including infectious disease, autoimmune disease, diabetes, and a chronic inflammatory dis...  
WO/2016/065264A1
Provided herein are compounds of formula (I) and compositions containing the compounds. The compounds and compositions are useful in the methods of treating, amelioration or prophylaxix of diseases associated with Nrf2/ NF-κΒ pathways....  
WO/2016/060488A3
The present invention relates to a method for producing an anhydrous sugar alcohol and, more specifically, to a method for producing an anhydrous sugar alcohol by dehydrating a sugar alcohol in the presence of a catalyst, which is capabl...  
WO/2016/060399A3
The present invention relates to a method for producing an anhydrous sugar alcohol and, more specifically, to a method for producing an anhydrous sugar alcohol using a solvent containing at least two components, which have a large differ...  
WO/2016/060398A3
The present invention relates to a method for producing an anhydrosugar alcohol by dehydrating a sugar alcohol at a high pressure in the presence of a catalyst being capable of inhibiting a side reaction at a high temperature and having ...  
WO/2016/058532A1
A method for preparing an isobenzofuran-1(3H)-one compound having the following formula I, wherein R1, R2 and p are as defined in the description.  
WO/2016/059205A1
The present invention relates to a process for the synthesis of 5-hydroxymethyl furfural (HMF) comprising the steps of: 1) dehydrating at least one saccharide selected from monosaccharides having 6 carbon atoms and disaccharides, oligosa...  
WO/2016/057660A8
Provided herein are compounds of formula (I) useful for the treatment of PPAR-delta related diseases (e.g. mitochondrial diseases, muscular diseases, vascular diseases, demyelinating diseases and metabolic diseases).  
WO/2016/057628A1
Methods for providing effective, efficient and convenient ways of producing 2,5-furandicarboxylic acid are presented. In addition, compositions of 2,5-furandicarboxylic acid including 2,5-furandicarboxylic acid and at least one byproduct...  
WO/2016/057660A1
Provided herein are compounds of formula (I) useful for the treatment of PPAR-delta related diseases (e.g. mitochondrial diseases, muscular diseases, vascular diseases, demyelinating diseases and metabolic diseases).  
WO/2016/057322A1
Provided herein are deuterated compounds and compositions useful in increasing PPAR5 activity. The compounds and compositions provided herein are useful for the treatment of PPAR5 related diseases (e.g., muscular diseases, vascular disea...  
WO/2016/057676A1
Methods for providing effective, efficient and convenient ways of producing 2-5-furandicarboxylic acid are presented. In addition, compositions of 2-5-furandicarboxylic acid including 2-5-furandicarboxylic acid, and at toast one byproduc...  
WO/2016/055196A1
The invention relates to a mono-and diester of 2,5-di(hydroxymethyl)-tetrahydrofuran, to methods for the production thereof by esterification in the presence of tertiary amines or in the presence of enzymatic esterfication catalysts and ...  
WO/2016/057687A1
Methods for providing effective, efficient and convenient ways of producing 2,5- furandicarboxylic acid, are presented, in addition, compositions of 2,5-furandicarboxylic acid including 2;5-furandicarboxylic acid and at Least one byprodu...  
WO/2016/056669A1
 Provided is a solid-supported ruthenium complex represented by general formula (1), (2) or (3). Further provided are: a method for manufacturing a reduction product by reducing an organic compound in the presence of the solid-supporte...  
WO/2016/056030A1
The present invention discloses a fast and selective process for the preparation of γ- valerolactone (Gvl) by catalytic hydrogenation of biomass-derived levulinic acid (LA) using recyclable ruthenium (Ru)-based heterogeneous catalysts i...  
WO/2016/057673A1
Methods for providing effective, efficient and convenient ways of producing 2,5- furandicarboxylic acid ate presented. In addition, compositions of 2,5-furandicarboxylic acid including 2,5 -furandicarboxylic acid and at least one byprodu...  
WO/2016/057682A1
Methods for providing effective, efficient and convenient ways of producing 2,5-furandicarboxylic acid are presented. In addition, compositions of 2,5-furandicarboxylic acid including 2,5-furandicarboxylic acid and at least one byproduct...  
WO/2016/055608A1
The present invention relates to a process for producing a water cleavage product, a water cleavage product thus produced, a process for producing at least one water cleavage secondary product, a water cleavage secondary product thus pro...  
WO/2016/049998A1
A fluorescent probe substrate for detecting the activity of human intestine carboxylesterase and uses thereof, which relate to the technical field of pharmaceuticals. The specific probe substrate is an aromatic ester (TCFE for short) of ...  
WO/2016/053938A1
The invention includes compositions comprising NSC59984 or a derivative or analogue thereof and a pharmaceutically acceptable carrier. The invention further includes methods of treating or preventing cancer in a subject, comprising the s...  
WO/2016/053186A1
There is provided a one-pot process for the conversion of sugars to furancarboxylic acids, such as 2,5-furancarboxylic acid (FDCA), in a triphasic system (e.g. water or tetraethylammonium bromide (TEAB) – methyl isobutyl ketone (MIBK) ...  
WO/2016/049774A1
Urea-based and bis-urea based compounds and analogues thereof are disclosed. These compounds are useful in the treatment of androgen-dependent diseases or disorders and androgen receptor-mediated diseases or disorders. Specifically, the ...  
WO/2016/045589A1
Disclosed is a method for preparing chiral γ-secondary amino alcohol. The method is characterized by comprising: adding into a solvent an acid addition salt, an alkali, a metal salt additive and a diphosphine-rhodium complex of β-secon...  
WO/2016/045587A1
Provided is a benzofuran analogue having a structure represented by formula (I) and used as an NS4B inhibitor, or a pharmaceutically acceptable salt of the benzofuran analogue. The benzofuran analogue has anti-hepatitis C virus activity.  
WO/2016/046575A1
A catalyst,method of using, and use of a hydrogenation catalyst, preferably palladium on a support, preferably alumina or activated charcoal support. This in the presence of lithium salts, with salts such as theborates being preferred. T...  
WO/2016/045415A1
A method for asymmetrically catalyzed synthesis of a γ-nitropyrazole amide compound, where a nitroalkene and an α,β-unsaturated pyrazole amide are employed as raw materials, a complex formed by a chiral amine oxide and a rare earth me...  
WO/2016/043589A1
The invention relates to the conversion of renewable biomass resources into valuable compounds. More specifically, it relates to the selective valorisation of 5-(hydroxymethyl)furfural into useful chemicals and fuels. Provided is a metho...  

Matches 151 - 200 out of 30,475